Plitidepsin

Aplidine is a compound found in tunicates which shows promise in shrinking tumors in pancreatic, stomach, bladder, and prostate cancers. The specific marine organism is Aplidium albicans. Aplidine consists of peptide molecules. In addition to the cancers mentioned above it is also under consideration as a treatment for some types of leukemia.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: 10-101-177

CAS No:137219-37-5

Synonyms/Alias:aplidin;aplidine;plitidepsin;dehydrodidemnin B;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C57H87N7O15
M.W/Mr.
1110.33858
Labeling Target
Vascular endothelial growth factor receptor
Application
Intended for the treatment of various forms of cancer.
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Activity
Agonist
Areas of Interest
Cancer

Plitidepsin, also known as dehydrodidemnin B, is a cyclic depsipeptide originally isolated from the marine tunicate Aplidium albicans. Characterized by its unique structure and potent biological activity, this compound has garnered significant interest in the scientific community for its diverse bioactive properties. Plitidepsin is distinguished by its ability to modulate cellular pathways and interact with key molecular targets, making it a valuable tool for researchers investigating cellular mechanisms and disease models. Its stability and compatibility with various experimental systems further enhance its appeal for laboratory applications, supporting its use in biochemical, cellular, and molecular biology studies.

Oncology Research: Plitidepsin serves as a powerful agent in oncology research, where it is utilized to study mechanisms of cell proliferation, apoptosis, and signal transduction in tumor cells. Researchers employ the compound to investigate its interactions with elongation factor 1A2 (eEF1A2), a protein implicated in cancer cell survival and proliferation. By modulating this target, plitidepsin facilitates the exploration of protein synthesis regulation and its downstream effects on cell viability, enabling the identification of novel pathways involved in tumorigenesis and the development of resistance to conventional therapies. The compound's unique mode of action provides a valuable platform for dissecting the molecular underpinnings of cancer progression and for screening potential synergistic effects with other investigational agents.

Virology Studies: In the field of virology, dehydrodidemnin B is leveraged to examine host-pathogen interactions, particularly its effects on viral replication cycles. Its capacity to interfere with host protein synthesis machinery offers researchers a means to investigate how viruses hijack cellular processes for their propagation. By selectively targeting eEF1A, plitidepsin enables detailed analysis of viral protein translation and the identification of host factors essential for viral life cycles. This approach aids in the elucidation of antiviral strategies that disrupt critical steps in viral replication, providing a foundation for the development of innovative research tools and experimental models.

Protein Synthesis Research: The ability of plitidepsin to modulate elongation factor activity makes it a valuable asset in protein synthesis research. Scientists utilize the compound to probe the intricacies of translational control, exploring how alterations in elongation factor function impact global protein expression. Such studies are instrumental in understanding the regulation of gene expression at the translational level and in identifying vulnerabilities within the protein synthesis machinery that may be exploited for research or therapeutic purposes. Plitidepsin's specificity and potency allow for precise manipulation of these pathways, facilitating the generation of robust experimental data.

Cell Signaling Pathway Analysis: Plitidepsin is employed in the analysis of complex cell signaling networks, particularly those governing cell cycle progression, stress responses, and programmed cell death. By modulating key signaling intermediates, the compound enables researchers to dissect the roles of specific pathways in maintaining cellular homeostasis or driving pathological changes. Its use in pathway mapping experiments provides insights into the dynamic interplay between signaling molecules and their downstream effectors, supporting the identification of novel regulatory nodes and potential intervention points for further study.

Natural Products Chemistry: In the realm of natural products chemistry, plitidepsin is an exemplar of marine-derived bioactive compounds. Its structural complexity and biological activity inspire the synthesis and modification of related molecules, fostering advances in the design of novel chemical entities. Researchers investigate its biosynthetic origins, structure-activity relationships, and the potential for generating analogs with enhanced or diversified properties. These efforts contribute to the broader understanding of marine natural products as a source of innovative research tools and bioactive scaffolds, driving discovery in chemical biology and related disciplines.

Source#
Synthetic
Long-term Storage Conditions
Soluble in DMSO, not soluble in water.
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Short-term Storage Conditions
Dry, dark and at 0 - 4 °C
Solubility
-20 °C
InChI
InChI=1S/C57H87N7O15/c1-15-33(8)46-44(66)29-45(67)79-49(32(6)7)48(68)34(9)50(69)58-39(26-30(2)3)54(73)64-25-17-19-41(64)56(75)62(13)43(28-37-20-22-38(77-14)23-21-37)57(76)78-36(11)47(52(71)59-46)60-51(70)42(27-31(4)5)61(12)55(74)40-18-16-24-63(40)53(72)35(10)65/h20-23,30-34,36,39-44,46-47,49,66H,15-19,24-29H2,1-14H3,(H,58,69)(H,59,71)(H,60,70)/t33-,34-,36+,39-,40-,41-,42+,43-,44-,46+,47-,49-/m0/s1
InChI Key
UUSZLLQJYRSZIS-LXNNNBEUSA-N
Isomeric SMILES
CC[C@H](C)[C@@H]1[C@H](CC(=O)O[C@H](C(=O)[C@@H](C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H]3CCCN3C(=O)C(=O)C)C)CC4=CC=C(C=C4)OC)C)CC(C)C)C)C(C)C)O
BoilingPoint
N/A
Melting Point
N/A

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Epitope Mapping ServicesPeptide Synthesis ServicesCustom Conjugation ServicePeptide Nucleic Acids SynthesiscGMP Peptide ServicePeptide Modification ServicesPeptide CDMOPeptide Analysis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers